Paradigm Biopharmaceuticals's market cap is currently $80.97M. The company's EPS TTM is $-0.021630015000000002; its P/E ratio is ―; Paradigm Biopharmaceuticals is scheduled to report earnings on August 29, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24
Jun 23
Jun 22
Jun 21
Jun 20
Currency in AUD
Paradigm Biopharmaceuticals Earnings and Revenue History
